Detalhe da pesquisa
1.
Carriage of multidrug-resistant Gram-negative bacilli: duration and risk factors.
Eur J Clin Microbiol Infect Dis
; 42(5): 631-638, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36964885
2.
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study).
Antimicrob Agents Chemother
; 65(8): e0004521, 2021 07 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33972253
3.
Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: when management reasoning eclipses evidence-based medicine.
J Antimicrob Chemother
; 75(11): 3096-3098, 2020 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32719877
4.
Post-CART-T Cell Infection: Etiology, pathogenesis, and therapeutic approaches.
Rev Esp Quimioter
; 36 Suppl 1: 52-53, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37997872
5.
Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view.
Rev Esp Quimioter
; 36(1): 65-81, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36510684
6.
Identifying the most important data for research in the field of infectious diseases: thinking on the basis of artificial intelligence.
Rev Esp Quimioter
; 36(6): 592-596, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37575020
7.
Recommendations on the use of azole antifungals in hematology-oncology patients.
Rev Esp Quimioter
; 36(3): 236-258, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37017117
8.
Antiviral drugs against SARS-CoV-2.
Rev Esp Quimioter
; 35 Suppl 3: 10-15, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36285850
9.
New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections.
Rev Esp Quimioter
; 35 Suppl 3: 51-53, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36285859
10.
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria.
Rev Esp Quimioter
; 35(5): 455-467, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35859521
11.
Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Open Forum Infect Dis
; 9(6): ofac180, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35615301
12.
Predictive factors, microbiology and outcome of patients with parapneumonic effusion.
Eur Respir J
; 38(5): 1173-9, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21565916
13.
Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
J Antimicrob Chemother
; 66(3): 657-63, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21193475
14.
Effect of statins on outcomes in immunosuppressed patients with bloodstream infection.
Eur J Clin Microbiol Infect Dis
; 30(1): 77-82, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20835878
15.
COVID-19 and fungal infections: Etiopathogenesis and therapeutic implications.
Rev Esp Quimioter
; 34 Suppl 1: 72-75, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34598433
16.
[A systematic review and expert's analysis of risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain]. / Revisión sistemática de la literatura y análisis de expertos sobre los factores de riesgo asociados a infecciones causadas por Pseudomonas aeruginosa o Acinetobacter baumannii resistentes a carbapenémicos en pacientes adultos en España.
Rev Esp Quimioter
; 34(4): 298-307, 2021 Aug.
Artigo
Espanhol
| MEDLINE | ID: mdl-33913312
17.
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Open Forum Infect Dis
; 8(6): ofab250, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34104670
18.
Real-life use of remdesivir in hospitalized patients with COVID-19.
Rev Esp Quimioter
; 34(2): 136-140, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33675220
19.
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement. / Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español.
Neurologia (Engl Ed)
; 36(1): 50-60, 2021.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-32561334
20.
Experience with the use of siltuximab in patients with SARS-CoV-2 infection.
Rev Esp Quimioter
; 34(4): 337-341, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33982984